BridgeBio Pharma, Inc 10-Q for FY2023 Q3
BridgeBio Pharma, Inc. (BBIO)
10-Q
2023-11-02
For: 2023-09-30
View Original
Added on
April 08, 2026
About this 10-Q
BridgeBio Pharma, Inc filed this 10-Q on November 2, 2023, covering the quarter ended September 30, 2023 (FY2023 Q3).
Headline figures
Quarter ended September 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $4.09M
- up 1110.4% from $338K a year earlier
- Net loss
- $179.49M
- compared with a net loss of $140.19M a year earlier
- Diluted EPS
- -$1.08
- compared with -$0.93 a year earlier